Skip to main content
SpringerLink
Log in

Sorafenib Use in Hepatocellular Carcinoma in Japan: Early Experience and Impact on Clinical Practice

  • Foreword
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World journal of gastroenterology: WJG 2006; 12(5): 828–9

    PubMed  Google Scholar 

  2. Ferlay J, Shin H, Bray F, Forman D, Mathers C and Parkin D. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. Available from URL: http://globocan.iarc.fr [Accessed: 2011 Nov 15]

    Google Scholar 

  3. American Cancer Society. What is liver cancer? Available from URL: http://www.cancer.org/Cancer/LiverCancer/DetailedGuide/liver-cancer-what-is-liver-cancer [Accessed: 2011 Nov 15]

  4. Easton A. Liver cancer toll high in Japan. British Medical Journal 1999; 318(7197): 1510

    Article  PubMed  CAS  Google Scholar 

  5. El-Serag H, Rudolf K. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132(7): 2557–76

    Article  PubMed  CAS  Google Scholar 

  6. Raoul JL, Sangro B, Forner A, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treatment Reviews 2011; 37(3): 212–20

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA

    Andrew X. Zhu

Authors
  1. Andrew X. Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, A.X. Sorafenib Use in Hepatocellular Carcinoma in Japan: Early Experience and Impact on Clinical Practice. Clin Drug Investig 32 (Suppl 2), 1–2 (2012). https://doi.org/10.1007/BF03265491

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03265491

Search

Navigation